vs
ACUITY INC. (DE)（AYI）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
ACUITY INC. (DE)的季度营收约是Royalty Pharma plc的1.8倍（$1.1B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 10.5%，领先23.9%），ACUITY INC. (DE)同比增速更快（20.2% vs 4.8%），过去两年ACUITY INC. (DE)的营收复合增速更高（12.4% vs 4.6%）
Squarespace是总部位于美国纽约的网站搭建与托管服务商，以SaaS模式提供一站式网站建设及托管服务，用户可借助平台预置的模板和拖拽式组件，无需专业代码能力即可快速创建、调整网页内容。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
AYI vs RPRX — 直观对比
营收规模更大
AYI
是对方的1.8倍
$622.0M
营收增速更快
AYI
高出15.4%
4.8%
净利率更高
RPRX
高出23.9%
10.5%
两年增速更快
AYI
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $622.0M |
| 净利润 | $120.5M | $214.2M |
| 毛利率 | 48.4% | — |
| 营业利润率 | 14.0% | 62.4% |
| 净利率 | 10.5% | 34.4% |
| 营收同比 | 20.2% | 4.8% |
| 净利润同比 | 12.9% | 2.9% |
| 每股收益（稀释后） | $3.82 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AYIRPRX
| Q4 25 | $1.1B | $622.0M | ||
| Q3 25 | $1.2B | $609.3M | ||
| Q2 25 | $1.2B | $578.7M | ||
| Q1 25 | $1.0B | $568.2M | ||
| Q4 24 | $951.6M | $593.6M | ||
| Q3 24 | $1.0B | $564.7M | ||
| Q2 24 | $968.1M | $537.3M | ||
| Q1 24 | $905.9M | $568.0M |
净利润AYIRPRX
| Q4 25 | $120.5M | $214.2M | ||
| Q3 25 | $114.0M | $288.2M | ||
| Q2 25 | $98.4M | $30.2M | ||
| Q1 25 | $77.5M | $238.3M | ||
| Q4 24 | $106.7M | $208.2M | ||
| Q3 24 | $118.9M | $544.0M | ||
| Q2 24 | $113.9M | $102.0M | ||
| Q1 24 | $89.2M | $4.8M |
毛利率AYIRPRX
| Q4 25 | 48.4% | — | ||
| Q3 25 | 48.9% | — | ||
| Q2 25 | 48.4% | — | ||
| Q1 25 | 46.5% | — | ||
| Q4 24 | 47.2% | — | ||
| Q3 24 | 47.3% | — | ||
| Q2 24 | 46.7% | — | ||
| Q1 24 | 45.5% | — |
营业利润率AYIRPRX
| Q4 25 | 14.0% | 62.4% | ||
| Q3 25 | 14.9% | 70.1% | ||
| Q2 25 | 11.9% | 36.3% | ||
| Q1 25 | 11.0% | 94.0% | ||
| Q4 24 | 14.0% | 60.9% | ||
| Q3 24 | 15.2% | — | ||
| Q2 24 | 15.0% | 50.2% | ||
| Q1 24 | 13.0% | -13.0% |
净利率AYIRPRX
| Q4 25 | 10.5% | 34.4% | ||
| Q3 25 | 9.4% | 47.3% | ||
| Q2 25 | 8.3% | 5.2% | ||
| Q1 25 | 7.7% | 41.9% | ||
| Q4 24 | 11.2% | 35.1% | ||
| Q3 24 | 11.5% | 96.3% | ||
| Q2 24 | 11.8% | 19.0% | ||
| Q1 24 | 9.8% | 0.8% |
每股收益（稀释后）AYIRPRX
| Q4 25 | $3.82 | $0.49 | ||
| Q3 25 | $3.61 | $0.67 | ||
| Q2 25 | $3.12 | $0.07 | ||
| Q1 25 | $2.45 | $0.55 | ||
| Q4 24 | $3.35 | $0.46 | ||
| Q3 24 | $3.77 | $1.21 | ||
| Q2 24 | $3.62 | $0.23 | ||
| Q1 24 | $2.84 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $376.1M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $2.8B | $9.7B |
| 总资产 | $4.7B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资AYIRPRX
| Q4 25 | $376.1M | $618.7M | ||
| Q3 25 | $422.5M | $938.9M | ||
| Q2 25 | $371.8M | $631.9M | ||
| Q1 25 | $397.9M | $1.1B | ||
| Q4 24 | $935.6M | $929.0M | ||
| Q3 24 | $845.8M | $950.1M | ||
| Q2 24 | $699.0M | $1.8B | ||
| Q1 24 | $578.9M | $843.0M |
总债务AYIRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益AYIRPRX
| Q4 25 | $2.8B | $9.7B | ||
| Q3 25 | $2.7B | $9.6B | ||
| Q2 25 | $2.6B | $9.5B | ||
| Q1 25 | $2.5B | $9.8B | ||
| Q4 24 | $2.5B | $10.3B | ||
| Q3 24 | $2.4B | $10.3B | ||
| Q2 24 | $2.3B | $9.8B | ||
| Q1 24 | $2.1B | $9.9B |
总资产AYIRPRX
| Q4 25 | $4.7B | $19.6B | ||
| Q3 25 | $4.8B | $19.3B | ||
| Q2 25 | $4.6B | $18.3B | ||
| Q1 25 | $4.6B | $17.6B | ||
| Q4 24 | $3.9B | $18.2B | ||
| Q3 24 | $3.8B | $18.0B | ||
| Q2 24 | $3.6B | $17.7B | ||
| Q1 24 | $3.5B | $16.1B |
负债/权益比AYIRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $140.8M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $114.8M | — |
| 自由现金流率自由现金流/营收 | 10.0% | — |
| 资本支出强度资本支出/营收 | 2.3% | — |
| 现金转化率经营现金流/净利润 | 1.17× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $534.5M | — |
8季度趋势，按日历期对齐
经营现金流AYIRPRX
| Q4 25 | $140.8M | $827.1M | ||
| Q3 25 | $202.5M | $702.6M | ||
| Q2 25 | $207.3M | $364.0M | ||
| Q1 25 | $59.4M | $596.1M | ||
| Q4 24 | $132.2M | $742.5M | ||
| Q3 24 | $174.1M | $703.6M | ||
| Q2 24 | $152.5M | $658.2M | ||
| Q1 24 | $102.6M | $664.6M |
自由现金流AYIRPRX
| Q4 25 | $114.8M | — | ||
| Q3 25 | $177.7M | — | ||
| Q2 25 | $192.3M | — | ||
| Q1 25 | $49.7M | — | ||
| Q4 24 | $113.3M | — | ||
| Q3 24 | $151.1M | — | ||
| Q2 24 | $140.5M | — | ||
| Q1 24 | $88.2M | — |
自由现金流率AYIRPRX
| Q4 25 | 10.0% | — | ||
| Q3 25 | 14.7% | — | ||
| Q2 25 | 16.3% | — | ||
| Q1 25 | 4.9% | — | ||
| Q4 24 | 11.9% | — | ||
| Q3 24 | 14.6% | — | ||
| Q2 24 | 14.5% | — | ||
| Q1 24 | 9.7% | — |
资本支出强度AYIRPRX
| Q4 25 | 2.3% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 1.6% | — |
现金转化率AYIRPRX
| Q4 25 | 1.17× | 3.86× | ||
| Q3 25 | 1.78× | 2.44× | ||
| Q2 25 | 2.11× | 12.06× | ||
| Q1 25 | 0.77× | 2.50× | ||
| Q4 24 | 1.24× | 3.57× | ||
| Q3 24 | 1.46× | 1.29× | ||
| Q2 24 | 1.34× | 6.45× | ||
| Q1 24 | 1.15× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AYI
| Sales Channel Through Independent Sales Network | $616.7M | 54% |
| Acuity Intelligent Spaces | $248.1M | 22% |
| QSCLLC | $95.1M | 8% |
| Sales Channel Through Direct Sales Network | $70.6M | 6% |
| Sales Channel Through Original Equipment Manufacturer And Other | $49.1M | 4% |
| Sales Channel Through Corporate Accounts Network | $40.7M | 4% |
| Sales Channel Through Retail | $40.3M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
